Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mind Medicine Mindmed Inc (NQ: MNMD )

4.000 +0.540 (+15.61%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,170,026
Open 3.530
Bid (Size) 4.140 (4)
Ask (Size) 4.200 (75)
Prev. Close 3.460
Today's Range 3.500 - 4.050
52wk Range 2.120 - 22.20
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The "Multi-Bagger" Portfolio Continued To Outperform The S&P 500 Last Week
Our basket of mostly microcap cannabis, psychedelic and plant-based food stocks was extremely oversold in 2022 but we're watching for them to bounce back in 2023. 
Via Talk Markets
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga

Performance

YTD
+60.64%
+60.64%
1 Month
+50.38%
+50.38%
3 Month
+50.94%
+50.94%
6 Month
-54.81%
-54.81%
1 Year
-78.32%
-78.32%

More News

Read More
The 7 Most Promising Psychedelic Stocks to Buy in February
Via InvestorPlace
6 Largest Psychedelic Stocks Down 3% This Week
Via Talk Markets
Psychedelic Stock Gainers And Losers From February 3, 2023
Via Benzinga
'Sea Change': Irwin Naturals, Numinus And Field Trip Discuss Psychedelics At Cantor Webinar
Via Benzinga
Psychedelic Stock Gainers And Losers From February 2, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 1, 2023
Via Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
Via Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
Via Benzinga
Top 3 Psychedelic Storylines To Watch In 2023
Via Benzinga
Summary Of Cannabis Category Performances, Week Ending Friday Jan. 27
Via Talk Markets
Largest Psychedelic Stocks +1.2% This Week; Now +16.1% YTD
Via Talk Markets
Cybin, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From January 26, 2023
Via Benzinga
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry
Via FinancialNewsMedia
Topics Economy
Exposures Supply Chain
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From January 23, 2023
Via Benzinga
Roundup: 5 Cannabis Category Performances
Via Talk Markets
Largest Psychedelic Stocks +3% This Week; Now +15% YTD
Via Talk Markets
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023
Via Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Drug Developer Mindset Pharma Optimistic About 2023 After Key 2022 Funding Collaborations And Patent Allowances
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.